Increased expression of u-PA and u-PAR on monocytes by LDL and Lp(a) lipoproteins - Consequences for plasmin generation and monocyte adhesion

Thrombosis and Haemostasis

Volumn 81, Issue 4, 1999, Pages 594-600

  Ganné, Florence ^a   Vasse, Marc ^a   Beaudeux, Jean Louis ^b   Peynet, Jacqueline ^b   François, Arnaud ^c   Paysant, Jérôme ^a   Lenormand, Bernard ^c   Collet, Jean Philippe ^d   Vannier, Jean Pierre ^a   Soria, Jeannette ^d   Soria, Claudine ^a,e  

^a UNIVERSITÉ DE ROUEN   (France)

^b Fac Des Sci Pharmaceutiques et B   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d HÔTEL DIEU   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PLASMIN; UROKINASE; UROKINASE RECEPTOR; VITRONECTIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CELL SURFACE; DOSE RESPONSE; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL ADHESION; FIBRINOGEN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIPOPROTEIN(A); LIPOPROTEINS; LIPOPROTEINS, LDL; MACROPHAGE-1 ANTIGEN; MONOCYTES; PLASMIN; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR; VITRONECTIN;

EID: 0032898212     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Castelli WB, Garrisson RJ, Wilson PWF, Abbott RD. Kaloudsian S, Kannel WB. The incidence of coronary bean disease and lipoprotein cholesterol levels: the Framingham study. JAMA 1986: 256: 2835-8.
2. Schaefer EJ. Lamon-Fava S. Jenner JL. McNamara JR. Ordovas JM. Davis CE. Abolafia JM, Lippel K, Levy RI. Lipoprotein(a) and risk of coronary heart disease in men. J AM A 1994:271:999-100.1
3. Sleinberg D. Parthasarathy S. Carew TE, Khoo JC. Witzum JL. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med 1989:320: 915-24.
4. Goldstein JL. Ho YK, Basu SK. Brown MS. Binding site on macrophages that mediates uptake and degradation of acety rated low density lipoprotein. producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979: 76: 333-7.
5. Bottalico LA, Keesler GA, Fless GM, Tabas I. Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoproteinlal internalization and degradation. J Biol Chem 1993; 268: 8569-73.
6. Ross R. Cell biology of atherosclerosis. Ann Rev Physiol 1995; 57: 791-804.
7. Thomas CE, Jackson RL, Ohlweiler DF. Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J Lipid Res 1994; 35:417-27.
8. Lipton BA. Parthasarathy S. Ord VA, Clinton SK. Libby P. Rosenfeld ME. Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophagesderived foam cells. J Lipid Res 1995: 36: 2232-42.
9. Brand K, Banka CL, Nackman N. Terkeltaub RA, Fan ST. Curtis LK. Oxidized low density lipoprotein enhances lipopolysaccharide-induced tissue factor expression in human monocytes. Arteriosder Thromb 1994; 14: 790-7.
10. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischémie death and crescendo angina. Br Heart J 1985; 53: 353-73.
11. Lee RT, Libby P. The unstable atheroma. Arteriosder Thromb Vase Biol 1997; 17: 1859-67.
12. Prediman K. Shah MD. Pathophysiology of plaque rupture and the concept of plaque stabilization. Cardiol Clin 1996:14: 17-29.
13. Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 1993: 15: 105-11.
14. Carmeliet P, Moons L, Lijnen R. Baes M, Lemaître V, Tipping P, Drew A, Eeckhout Y, Shapiro S. Lupu F, Collen D. Urokinase-generated plasmin activates matrix raetalloproteinases during aneurysm formation. Nature genetics 1997:17:439-44.
15. Waltz DA. Chapman HA. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem 1994; 269: 14746-50,
16. Kanse SM. Kost C. Wilhem OG. Andreasen PA. Preissner KT. The urokinase receptor is a major vitronectin-bindtng protein on endothelial cells. Exp Cell Res 1996; 224: 344-53.
17. Waltz DA, Sailor LZ, Chapman HA. Cytokines induce urokinase-dependant adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J Clin Invest 199.3: 91: 1541-52.
18. Simon Dl. Rao NK, Xu H, Wei Y. Majdic O, Ronne E. Kobzik L. Chapman HA. Mac-1 ICDl lb/CD18> and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood 1996; 88: 3185-94.
19. Sitrin RG. Todd RF. Petty HR. Brock TG, Shollenberg SB, Albrecht E, Gyetko MR. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 1996:97: 1942-51.
20. Languino LR. Plescia J, Duperray A. Brian AA. Plow EF. Geltosky JE, Altieri DC. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1 dependent pathway. Cell 1993: 73: 1423-34.
21. Kamboh MI, Ferrel RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 1991; 49: 1063-74.
22. Beaudeux JL, Ćesarini ML. Gardès-Albert M. Maclouf J. Meval R. Esposito B. Peynet J, Tedgui A. Native and γ radiolysis-oxidized lipoprotein(a) increase the adhesiveness of rabbit aortic endothelium. Atherosclerosis 1997: 132: 29-35.
23. Lowry OH, Rosebrough NJ, Farr AL. Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
24. Todd III RF. Barnathan ES. Bohuslav J, Chapman HA, Cohen RL, Felez J, Howell A. Johnson JG. Knapp W. Kramer M. Miles LA. Nykjaer A, Ralfkiaer E. Schuren E. Leukocyte Typing V: White Cells Differentiation Antigens. In: CD87 cluster workshop report. Schlossman S, Boumsell L, Gilks W, eds. New York: Oxford University Press 1995; 932-7.
25. Wiztum JL, Teinberg D. Role of oxidized LDL in atherogenesis. J Clin Invest 1991; 88: 1785-92.
26. Moreno PR. Falk E, Palacios IF, Newell JB, Fuster V. Fallon JT. Macrophage infiltration in acute coronary syndrome: Implications for plaque rupture. Circulation 1994; 90: 775-8.
27. Galis Z. Sukhova G. Kranzhofer R. Clark S. Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995; 92: 402-6.
28. Lee SW, Ellis V, Dichek DA. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase. J Biol Chem 1994; 269: 2411-8.
29. Hsu HY, Hajjar DP, Faisal Khan KM Falcone DJ. Ligand binding to macrophages scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway. J Biol Chem 1998; 273: 1240-6.
30. Falcone DJ. McCaffrey TA, Haimovitz-Friedman A. Vergilio JA. Nicholson AC. Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem 1993; 268: 11951-8.
31. Ritchie H, Jamieson A. Booth NA. Peripheral blood monocyte synthesis of plasminogen activator inhibitor 2 in response to native and modified LDL. Thromb Haemost 1995; 74: 1521-7.
32. Tipping PG. Davenport P, Gallicchio M, Filonzi EL, Apostolopoulos J, Wojta J. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells. Am J Pathol 1993; 143: 875-85.
33. Smith EB, Thompson W. Fibrin as a risk factor in atherogenesis. Thromb Res 1994; 73: 1-19.
34. Dufourcq P. Louis H. Moreau C. Daret D. Boisseau MR. Lamazière JMD. Bonnet J. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vase Biol 1998; 18: 168-76.